Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Stem Cell Research

  Free Subscription


Articles published in Exp Hematol

Retrieve available abstracts of 56 articles:
HTML format



Single Articles


    March 2023
  1. HONG T, Wang R, Yang G, Wang X, et al
    Human umbilical cord mesenchymal stem cells ameliorate acute graft versus host disease by elevating phytosphingosine.
    Exp Hematol. 2023 Mar 15:S0301-472X(23)00070.
    PubMed     Abstract available


  2. NOWICKI M, Wierzbowska A, Szymanska B, Nowicki G, et al
    Inflammation-related mRNA expression in patients with multiple myeloma undergoing hematopoietic stem cell mobilization.
    Exp Hematol. 2023 Mar 9:S0301-472X(23)00069-3. doi: 10.1016/j.exphem.2023.
    PubMed     Abstract available


  3. AZADPOUR S, Abdossamadi S, Ng B, Ostroumov E, et al
    Circulating Cell Free Mitochondrial DNA As a Diagnostic and Prognostic Biomarker in Chronic and Late Acute Graft-versus-Host Disease in Children.
    Exp Hematol. 2023 Mar 1:S0301-472X(23)00032-2. doi: 10.1016/j.exphem.2023.
    PubMed     Abstract available


    February 2023
  4. VINK CS, Dzierzak E
    The (intra-aortic) hematopoietic cluster cocktail: what is in the mix?
    Exp Hematol. 2023;118:1-11.
    PubMed     Abstract available


    January 2023
  5. SCHONUNG M, Hartmann M, Kramer S, Stable S, et al
    Dynamic DNA methylation reveals novel cis-regulatory elements in mouse hematopoiesis.
    Exp Hematol. 2023;117:24-42.
    PubMed     Abstract available


  6. MISTRY JJ, Bowles K, Rushworth SA
    HSC-derived fatty acid oxidation in steady-state and stressed hematopoiesis.
    Exp Hematol. 2023;117:1-8.
    PubMed     Abstract available


    December 2022
  7. RILEY JS, McClain LE, Stratigis JD, Coons BE, et al
    Fetal allotransplant recipients are resistant to graft-versus-host disease.
    Exp Hematol. 2022 Dec 16:S0301-472X(22)00839.
    PubMed     Abstract available


  8. CAMPANELLI R, Abba C, Carolei A, Catarsi P, et al
    Cells coexpressing both myeloid and endothelial markers are detectable in the spleen and bone marrow of patients with primary myelofibrosis.
    Exp Hematol. 2022;116:26-29.
    PubMed     Abstract available


  9. CATARINO TA, Pacheco-Leyva I, Al-Dalali F, Ghezzo MN, et al
    Cdkn2a inactivation promotes malignant transformation of mouse immature thymocytes before the beta-selection checkpoint.
    Exp Hematol. 2022;116:30-36.
    PubMed    


    November 2022
  10. LIU C, Imai M, Edahiro Y, Mano S, et al
    Establishment of isogenic induced pluripotent stem cells with or without pathogenic mutation for understanding the pathogenesis of myeloproliferative neoplasms.
    Exp Hematol. 2022 Nov 26:S0301-472X(22)00809.
    PubMed     Abstract available


  11. CARNEIRO TX, Marrese DG, Santos MGD, Goncalves MV, et al
    Circulating Extracellular Vesicles as a Predictive Biomarker for Acute Graft-Versus-Host Disease.
    Exp Hematol. 2022 Nov 15. pii: S0301-472X(22)00808.
    PubMed     Abstract available


  12. DITADI A, Sturgeon CM
    Back to the Future: lessons from development drive innovation of human pluripotent stem cell therapies.
    Exp Hematol. 2022 Nov 15. pii: S0301-472X(22)00806.
    PubMed    


  13. ZEMAITIS K, Subramaniam A, Galeev R, Prosz A, et al
    RNAi Screen Identifies MTA1 as an Epigenetic Modifier of Differentiation Commitment in Human HSPCs.
    Exp Hematol. 2022;115:20-29.
    PubMed     Abstract available


    October 2022
  14. PURTON LE
    Adult murine hematopoietic stem cells and progenitors: an update on their identities, functions and assays.
    Exp Hematol. 2022 Oct 22. pii: S0301-472X(22)00757.
    PubMed     Abstract available


  15. KENT DG
    Hematopoietic Stem cells depend on HIM and HER.
    Exp Hematol. 2022 Oct 17. pii: S0301-472X(22)00754.
    PubMed    


    September 2022
  16. PATEL SB, Kuznetsova V, Matkins VR, Franceski AM, et al
    Ex vivo expansion of phenotypic and transcriptomic CML stem cells.
    Exp Hematol. 2022 Sep 14. pii: S0301-472X(22)00696.
    PubMed     Abstract available


    August 2022
  17. STODDART A, Fernald AA, Davis EM, McNerney ME, et al
    EGR1 haploinsufficiency confers a fitness advantage to hematopoietic stem cells following chemotherapy.
    Exp Hematol. 2022 Aug 19. pii: S0301-472X(22)00679.
    PubMed     Abstract available


  18. DANNENMANN B, Zahabi A, Mir P, Oswald B, et al
    Corrigendum to 'Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34+ cells preceding leukemic transformation' <[Experimental Hematology, Volume 71, 2019;71:51-60]>.
    Exp Hematol. 2022 Aug 8. pii: S0301-472X(22)00580.
    PubMed    


  19. FUJITA S, Morikawa T, Tamaki S, Sezaki M, et al
    Quantitative Analysis of Sympathetic and Nociceptive Innervation Across Bone Marrow Regions in Mice.
    Exp Hematol. 2022;112-113:44-59.
    PubMed     Abstract available


  20. KHAMPHIKHAM P, Wongborisuth C, Pornprasert S, Tantiworawit A, et al
    IOX1 Fails to Reduce alpha-Globin and Mediates gamma-Globin Silencing in Adult beta(0)-Thalassemia/Hemoglobin E Erythroid Progenitor Cells.
    Exp Hematol. 2022;112-113:9-14.
    PubMed     Abstract available


  21. MORALES-MANTILLA DE, King KY
    FGD5 marks a subpopulation of hematopoietic stem and progenitor cells that resist interferon-gamma-mediated differentiation.
    Exp Hematol. 2022;112-113:35-43.
    PubMed     Abstract available


    July 2022
  22. QIU J, Ghaffari S
    Mitochondrial Deep Dive into Hematopoietic Stem Cell Dormancy: Not Much Glycolysis but Plenty of Sluggish Lysosomes.
    Exp Hematol. 2022 Jul 28. pii: S0301-472X(22)00577.
    PubMed     Abstract available


  23. SOMMERKAMP P, Brown JA, Haltalli MLR, Mercier FE, et al
    m(6)A RNA modifications: Key regulators of normal and malignant hematopoiesis.
    Exp Hematol. 2022;111:25-31.
    PubMed     Abstract available


    June 2022
  24. STALMANN USA, Banjanin B, Snoeren IAM, Nagai JS, et al
    Single-cell analysis of cultured bone marrow stromal cells reveals high similarity to fibroblasts in situ.
    Exp Hematol. 2022;110:28-33.
    PubMed     Abstract available


    May 2022
  25. HAMMOND CA, Eaves CJ
    Postnatal conservation of human blood- and marrow-specific CD34(+) hematopoietic phenotypes.
    Exp Hematol. 2022;109:18-26.
    PubMed     Abstract available


    April 2022
  26. WILKES MC, Scanlon V, Shibuya A, Celika AM, et al
    Downregulation of SATB1 by miRNAs Reduces Megakaryocyte/Erythroid Progenitor Expansion in pre-clinical models of Diamond Blackfan Anemia.
    Exp Hematol. 2022 Apr 20. pii: S0301-472X(22)00202.
    PubMed     Abstract available


    March 2022
  27. GERRITSEN M, Hilgendorf S, Yi G, Wierenga ATJ, et al
    Presence of mutant p53 increases stem-cell frequency and is associated with reduced binding to classical TP53 binding sites in cell lines and primary AMLs.
    Exp Hematol. 2022 Mar 18. pii: S0301-472X(22)00128.
    PubMed     Abstract available


  28. YAN Y, Upadhyaya R, Zhang VW, Berg T, et al
    Epigenetic Maintenance Strategies after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia.
    Exp Hematol. 2022 Mar 11. pii: S0301-472X(22)00122.
    PubMed     Abstract available


  29. HIGO T, Suzuki Y, Sato M, Koya J, et al
    Heterozygous Dnmt3a R878C Induces Expansion of Quiescent Hematopoietic Stem Cell Pool.
    Exp Hematol. 2022 Mar 1. pii: S0301-472X(22)00076.
    PubMed     Abstract available


  30. ALTROCK E, Sens-Albert C, Jann JC, Flach J, et al
    Humanized three-dimensional scaffold xenotransplantation models for myelodysplastic syndromes.
    Exp Hematol. 2022;107:38-50.
    PubMed     Abstract available


    February 2022
  31. ULYANOVA T, Cherone JM, Sova P, Papayannopoulou T, et al
    alpha4-Integrin deficiency in human CD34(+) cells engenders precocious erythroid differentiation but inhibits enucleation.
    Exp Hematol. 2022 Feb 26. pii: S0301-472X(22)00038.
    PubMed     Abstract available


  32. KIUMARSI A, Mousavi SA, Kasaeian A, Rostami T, et al
    Radiation-free Reduced-intensity Hematopoietic Stem Cell Transplantation with In-Vivo T-cell Depletion from Matched Related and Unrelated Donors for Fanconi Anemia: Prognostic Factor Analysis.
    Exp Hematol. 2022 Feb 21. pii: S0301-472X(22)00071.
    PubMed     Abstract available


  33. HIDALGO I, Wahlestedt M, Yuan O, Zhang Q, et al
    Bmi1 induction protects hematopoietic stem cells against pronounced long-term hematopoietic stress.
    Exp Hematol. 2022 Feb 19. pii: S0301-472X(22)00072.
    PubMed     Abstract available


  34. ZHANG Y, Xu Y, Zhang S, Lu Z, et al
    The regulation roles of Ca(2+) in erythropoiesis: What have we learned?
    Exp Hematol. 2022;106:19-30.
    PubMed     Abstract available


    January 2022
  35. SARRAF AA, Schetelig J, Baldauf H, Stolzel F, et al
    Macroscopic, histologic, and clinical assessment of acute graft-versus-host disease of the upper gastrointestinal tract within 6 weeks after allogeneic hematopoietic cell transplantation.
    Exp Hematol. 2022 Jan 13. pii: S0301-472X(22)00033.
    PubMed     Abstract available


  36. BATEY K, Kim J, Brinster L, Gonzalez-Matias G, et al
    Residual effects of busulfan and irradiation on murine hematopoietic stem and progenitor cells.
    Exp Hematol. 2022;105:22-31.
    PubMed     Abstract available


    December 2021
  37. HALTALLI MLR, Wilkinson AC, Rodriguez-Fraticelli A, Porteus M, et al
    Hematopoietic stem cell gene editing and expansion: state-of-the-art technologies and recent applications.
    Exp Hematol. 2021 Dec 29. pii: S0301-472X(21)00858.
    PubMed     Abstract available


  38. RODRIGUEZ Y BAENA A, Manso BA, Forsberg EC
    CFU-S assay: a historical single-cell assay that offers modern insight into clonal hematopoiesis.
    Exp Hematol. 2021;104:1-8.
    PubMed     Abstract available


  39. HE X, Zhang Y, Xu Y, Xie L, et al
    Function of the P2X7 receptor in hematopoiesis and leukemogenesis.
    Exp Hematol. 2021;104:40-47.
    PubMed     Abstract available


  40. MENDE N, Laurenti E
    Hematopoietic stem and progenitor cells outside the bone marrow: where, when, and why.
    Exp Hematol. 2021;104:9-16.
    PubMed     Abstract available


  41. CHALLEN GA, Pietras EM, Wallscheid NC, Signer RAJ, et al
    Simplified murine multipotent progenitor isolation scheme: Establishing a consensus approach for multipotent progenitor identification.
    Exp Hematol. 2021;104:55-63.
    PubMed     Abstract available


    November 2021
  42. IGARASHI K, Hori T, Yamamoto M, Sohma H, et al
    CCL8 deficiency in the host abrogates early mortality of acute graft-versus-host disease in mice with dysregulated IL-6 expression.
    Exp Hematol. 2021 Nov 19. pii: S0301-472X(21)00429.
    PubMed     Abstract available


  43. ZOU J, Shi Q, Chen H, Juskevicius R, et al
    Programmed necroptosis is upregulated in low-grade myelodysplastic syndromes and may play a role in the pathogenesis.
    Exp Hematol. 2021;103:60-72.
    PubMed     Abstract available


    September 2021
  44. LI Y, Magee JA
    Transcriptional reprogramming in neonatal hematopoietic stem and progenitor cells.
    Exp Hematol. 2021;101-102:25-33.
    PubMed     Abstract available


  45. NAKAJIMA H, Murakami K
    O-GlcNAcylation: Implications in normal and malignant hematopoiesis.
    Exp Hematol. 2021;101-102:16-24.
    PubMed     Abstract available


    August 2021
  46. LEVESQUE JP, Summers KM, Millard SM, Bisht K, et al
    Role of macrophages and phagocytes in orchestrating normal and pathologic hematopoietic niches.
    Exp Hematol. 2021;100:12-31.
    PubMed     Abstract available


  47. MEZA-LEON B, Gratzinger D, Aguilar-Navarro AG, Juarez-Aguilar FG, et al
    Human, mouse, and dog bone marrow show similar mesenchymal stromal cells within a distinctive microenvironment.
    Exp Hematol. 2021;100:41-51.
    PubMed     Abstract available


    July 2021
  48. HUPPERTZ S, Senger K, Brown A, Leins H, et al
    KDM6A, a histone demethylase, regulates stress hematopoiesis and early B-cell differentiation.
    Exp Hematol. 2021;99:32-43.
    PubMed     Abstract available


    May 2021
  49. GRANDITS AM, Wieser R
    Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A.
    Exp Hematol. 2021 May 21. pii: S0301-472X(21)00195.
    PubMed     Abstract available


  50. TAN G, Meier-Abt F
    Differential expression of hydroxyurea transporters in normal and polycythemia vera hematopoietic stem and progenitor cell subpopulations.
    Exp Hematol. 2021;97:47-56.
    PubMed     Abstract available


  51. BAPAT A, Schippel N, Shi X, Jasbi P, et al
    Hypoxia promotes erythroid differentiation through the development of progenitors and proerythroblasts.
    Exp Hematol. 2021;97:32-46.
    PubMed     Abstract available


    April 2021
  52. KATAGIRI T, Uemura S, Ushiki T, Nakajima-Takagi Y, et al
    Distinct effects of chondroitin sulfate on hematopoietic cells and the stromal microenvironment in bone marrow hematopoiesis.
    Exp Hematol. 2021;96:52-62.
    PubMed     Abstract available


  53. DEMERDASH Y, Kain B, Essers MAG, King KY, et al
    Yin and Yang: The dual effects of interferons on hematopoiesis.
    Exp Hematol. 2021;96:1-12.
    PubMed     Abstract available


  54. LI S, Yao JC, Li JT, Schmidt AP, et al
    TLR7/8 agonist treatment induces an increase in bone marrow resident dendritic cells and hematopoietic progenitor expansion and mobilization.
    Exp Hematol. 2021;96:35-43.
    PubMed     Abstract available


  55. TERMINI CM, Pang A, Batton DM, Chute JP, et al
    Proteoglycans regulate protein tyrosine phosphatase receptor sigma organization on hematopoietic stem/progenitor cells.
    Exp Hematol. 2021;96:44-51.
    PubMed     Abstract available


    February 2021
  56. DOTY RT, Yan X, Meng C, Lausted C, et al
    Single-cell analysis of erythropoiesis in Rpl11 haploinsufficient mice reveals insight into the pathogenesis of Diamond Blackfan anemia.
    Exp Hematol. 2021 Feb 22. pii: S0301-472X(21)00092.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: